Intangible Assets

Goodwill



(In thousands)	CooperVision			CooperSurgical			Total
Balance as of October 31, 2013	$	1,048,478		$	339,133		$	1,387,611
Net additions during the year ended October 31, 2014	857,146			25,543			882,689
Translation	(44,063		)	(5,316		)	(49,379		)
Balance as of October 31, 2014	1,861,561			359,360			2,220,921
Net reductions during the nine-month period ended July 31, 2015	(1,189		)	(8		)	(1,197		)
Translation	(23,306		)	(7,265		)	(30,571		)
Balance as of July 31, 2015	$	1,837,066		$	352,087		$	2,189,153

We performed our annual impairment assessment in our fiscal third quarter of 2015, and our analysis indicated that we had no impairment of goodwill. We performed our annual impairment assessment in our fiscal third quarter of 2014, and our analysis indicated that we had no impairment of goodwill. We evaluate goodwill for impairment annually during the fiscal third quarter and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. We account for goodwill and evaluate our goodwill balances and test them for impairment in accordance with related accounting standards.

In fiscal 2015 and 2014, we performed a qualitative assessment to test each reporting unit's goodwill for impairment. Qualitative factors considered in this assessment include industry and market considerations, overall financial performance and other relevant events and factors affecting each reporting unit. Based on our qualitative assessment, if we determine that the fair value of a reporting unit is more likely than not to be less than its carrying amount, the two step impairment test will be performed. Initially, we compare the book value of net assets to the fair value of each reporting unit that has goodwill assigned to it. If the fair value is determined to be less than the book value, a second step is performed to compute the amount of the impairment. A reporting unit is the level of reporting at which goodwill is tested for impairment. Our reporting units are the same as our business segments - CooperVision and CooperSurgical - reflecting the way that we manage our business.

Goodwill impairment analysis and measurement is a process that requires significant judgment. If our common stock price trades below book value per share, there are changes in market conditions or a future downturn in our business, or a future annual goodwill impairment test indicates an impairment of our goodwill, we may have to recognize a non-cash impairment of goodwill that could be material and could adversely affect our results of operations in the period recognized and also adversely affect our total assets, stockholders' equity and financial condition.

Other Intangible Assets



	As of July 31, 2015				As of October 31, 2014
(In thousands)	Gross Carrying Amount		Accumulated Amortization & Translation		Gross Carrying Amount		Accumulated Amortization & Translation
Trademarks	$	20,546	$	3,938	$	21,281	$	2,937
Technology	320,447		109,617		326,620		93,780
Customer relationships	226,588		100,463		233,246		90,704
License and distribution rights and other	72,228		23,505		73,479		13,600
	639,809		$	237,523	654,626		$	201,021
Less accumulated amortization and translation	237,523				201,021
Other intangible assets, net	$	402,286			$	453,605

We estimate that amortization expense for our existing other intangible assets at July 31, 2015, will be $50.9 million in fiscal 2015, $48.5 million in fiscal 2016, $45.2 million in fiscal 2017, $43.3 million in fiscal 2018 and $40.5 million in fiscal 2019.